We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights PepsiCo, Thermo Fisher Scientific, Canadian National Railway, Occidental Petroleum and Truist Financial
Read MoreHide Full Article
For Immediate Release
Chicago, IL – October 10, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: PepsiCo, Inc. (PEP - Free Report) , Thermo Fisher Scientific Inc. (TMO - Free Report) , Canadian National Railway Co. (CNI - Free Report) , Occidental Petroleum Corp. (OXY - Free Report) and Truist Financial Corp. (TFC - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Stock Reports for PepsiCo, Thermo Fisher and Canadian National
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including PepsiCo, Inc., Thermo Fisher Scientific Inc. and Canadian National Railway Co. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
PepsiCo shares have handily outperformed the S&P 500 index this year (-6.9% vs. -22%), though they have done only modestly better than rival Coke's -7.6% decline. We will see if performance momentum can be sustained following the company's quarterly results next week.
PepsiCo benefits from the resilience and strength of global beverage and convenient food businesses. It expects to benefit by delivering convenience, variety and value proposition to customers through its brands. It raised its revenue view for 2022.
However, it witnessed margin pressures in the second quarter driven by impacts of supply-chain disruptions and inflationary labor, transportation and commodity costs. PEP anticipates incremental input cost inflation for the balance of 2022. Adverse currency rates also remain headwinds.
Thermo Fisher Scientific's shares have declined -7.3% over the past year against the Zacks Medical - Instruments industry’s decline of -32.0%, with the improved performance reflecting favorable outlook for the Analytical Instruments, Laboratory Products and Biopharma Services business lines. The company’s strategic acquisitions of PPD, Inc. and PeproTech raise investors’ confidence.
Thermo Fisher’s accelerated investments to expand bioproduction capacity also buoy optimism. The upbeat guidance for 2022 is indicative that this growth momentum will continue.
Canadian National Railway's shares have declined -4.0% over the past year against the Zacks Transportation - Rail industry’s decline of -9.1%. The company is facing supply chain disruptions, network fluidity challenges and weak Canadian grain crops are hurting the company’s volumes. Escalating fuel prices amid the Russia-Ukraine war pose a threat to Canadian National's bottom line. The company’s weak liquidity position is an added concern.
However, In January, Canadian National Railway has announced a 19% dividend hike. Canadian National is also active on the share buyback front. Strong cash flow generating-ability supports Canadian National's shareholder-friendly activities.
The company is benefiting from strong freight demand and solid pricing. With this, management expects adjusted earnings to increase 15-20% year over year in the current year.
Other noteworthy reports we are featuring today include Occidental Petroleum Corp. and Truist Financial Corp.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights PepsiCo, Thermo Fisher Scientific, Canadian National Railway, Occidental Petroleum and Truist Financial
For Immediate Release
Chicago, IL – October 10, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: PepsiCo, Inc. (PEP - Free Report) , Thermo Fisher Scientific Inc. (TMO - Free Report) , Canadian National Railway Co. (CNI - Free Report) , Occidental Petroleum Corp. (OXY - Free Report) and Truist Financial Corp. (TFC - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Stock Reports for PepsiCo, Thermo Fisher and Canadian National
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including PepsiCo, Inc., Thermo Fisher Scientific Inc. and Canadian National Railway Co. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
PepsiCo shares have handily outperformed the S&P 500 index this year (-6.9% vs. -22%), though they have done only modestly better than rival Coke's -7.6% decline. We will see if performance momentum can be sustained following the company's quarterly results next week.
PepsiCo benefits from the resilience and strength of global beverage and convenient food businesses. It expects to benefit by delivering convenience, variety and value proposition to customers through its brands. It raised its revenue view for 2022.
However, it witnessed margin pressures in the second quarter driven by impacts of supply-chain disruptions and inflationary labor, transportation and commodity costs. PEP anticipates incremental input cost inflation for the balance of 2022. Adverse currency rates also remain headwinds.
(You can read the full research report on PepsiCo here >>>)
Thermo Fisher Scientific's shares have declined -7.3% over the past year against the Zacks Medical - Instruments industry’s decline of -32.0%, with the improved performance reflecting favorable outlook for the Analytical Instruments, Laboratory Products and Biopharma Services business lines. The company’s strategic acquisitions of PPD, Inc. and PeproTech raise investors’ confidence.
Thermo Fisher’s accelerated investments to expand bioproduction capacity also buoy optimism. The upbeat guidance for 2022 is indicative that this growth momentum will continue.
(You can read the full research report on Thermo Fisher Scientific here >>>)
Canadian National Railway's shares have declined -4.0% over the past year against the Zacks Transportation - Rail industry’s decline of -9.1%. The company is facing supply chain disruptions, network fluidity challenges and weak Canadian grain crops are hurting the company’s volumes. Escalating fuel prices amid the Russia-Ukraine war pose a threat to Canadian National's bottom line. The company’s weak liquidity position is an added concern.
However, In January, Canadian National Railway has announced a 19% dividend hike. Canadian National is also active on the share buyback front. Strong cash flow generating-ability supports Canadian National's shareholder-friendly activities.
The company is benefiting from strong freight demand and solid pricing. With this, management expects adjusted earnings to increase 15-20% year over year in the current year.
(You can read the full research report on Canadian National Railway here >>>)
Other noteworthy reports we are featuring today include Occidental Petroleum Corp. and Truist Financial Corp.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.